Home  >  Products  >  PRKAG3 (protein kinase, AMP-activated, gamma 3 non-catalytic subunit ) Blocking Peptide (the N terminal of PRKAG3)(100ug)
PRKAG3 (protein kinase, AMP-activated, gamma 3 non-catalytic subunit ) Blocking Peptide (the N terminal of PRKAG3)(100ug)

PRKAG3 (protein kinase, AMP-activated, gamma 3 non-catalytic subunit ) Blocking Peptide (the N terminal of PRKAG3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PRKAG3 Antibody (ARP64048_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64048
Size: 100ug
Weight: 54kDa
Gene: 53632
Format: Lyophilized powder
Target: The protein encoded by this gene is a regulatory subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This subunit is one of the gamma regulatory subunits of AMPK. It is dominantly expressed in skeletal muscle. Studies of the pig counterpart suggest that this subunit may play a key role in the regulation of energy metabolism in skeletal muscle.
Alternative names: AMPKG3
See Full Product Listings >